09/24/2019 | Luke Turner
A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer
07/29/2019 | Brett Spangler
How primary neuronal cell cultures are unraveling the role of amyloid β oligomers in Alzheimer’s disease.
07/23/2019
Sitting Down With… Mike Clayman, CEO of Flexion Therapeutics, Inc., Burlington, Massachusetts, USA.
07/12/2019 | Stephanie Sutton
RNA Inhibitors - an exciting avenue for drug development? We collate the findings from the Innovation that Matters series, hosted by WuXi Xpress...
07/12/2019 | Jonathan James
Sitting Down with Michael Tanner, Research Fellow in the School of Engineering and Physical Sciences at Heriot Watt University, Edinburgh, UK.
07/05/2019 | Jonathan James
Researchers fine-tune 3D printing technology to create better biomimetic corneas – and predict a “breakthrough” in global transplantation practice.
07/05/2019 | Michael Schubert
A new study uses machine learning to perform meta-analysis of eight metagenomic studies linking gut microbial signatures with colorectal cancer.
06/28/2019 | Jonathan James
Could modulation of fibroblast growth factor 21 translate into a new treatment for non-alcoholic fatty liver disease?
06/25/2019 | Danny Ward
To truly understand the intricacies of pathogenic bacteria, we need to combine “pure” and translational research.
06/21/2019 | Jonathan James
Combining metabolomics and DNA sequencing could be the key to discovering new inborn errors of metabolism in children.
06/20/2019 | Luke Turner
We sit down with digital pathology advocate David Wilbur to discuss how the advancement of digital interfaces could lead to widespread adoption.
06/17/2019 | Jonathan James
The application of CRISPR on a genome-wide scale provides a major insight into tumor dependency.
06/12/2019 | Jonathan James
Artificial intelligence holds the key to improving embryo selection for in vitro fertilization.
Send me the latest from The Translational Scientist.
10/07/2019 | Contributed by ForteBio
09/10/2019 | Contributed by ForteBio
07/09/2019 | Contributed by ForteBio
03/23/2018 | Contributed by Thermo Fisher Scientific
04/09/2019 | Sponsored by Andor
The webinar will look at efforts to translate researched multimodal spectroscopic approaches into automated systems with a high technology readiness level (TRL) for clinical applications.
05/26/2016 | Sponsored by Thermo Fisher Scientific
Learn how studying the kinome as a whole entity, can aide in understanding how tumors may evade current therapies by altering their kinome state.
11/23/2016 | William Aryitey
Bioelectronics now allows neurotransmitter release at the speed of biological nerves
09/28/2016 | William Aryitey
Tightly controlled efficacy studies can’t predict real-word effectiveness
06/27/2017 | Roisin McGuigan
A recent clinical trial finds a new use for an old antibiotic.
05/26/2016 | Joe Beckman
When it comes to prognosis, the mouse models I use to study amyotrophic lateral sclerosis (ALS) are sadly accurate – like their human counterparts with familial ALS, all mice with these mutations die young. After 20 years of trying – and failing – to find a treatment that could extend life, I was close to giving up, until a new drug candidate came along. Then something amazing happened – a mouse lived.
03/02/2016 | James Ritchie, Sidath Katugampola, Paul Jones
The vast majority of experimental cancer drugs fail during the later stages of clinical development
05/21/2019 | Jonathan James
How early telltales of tumors are frequently missed by both patients and clinicians
02/12/2019 | Jonathan James
How will the storm whipped up by He Juinkai’s flagrant disregard for medical ethics affect the wider ambitions of the gene-editing field?
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register